GPC4 and glioblastoma: The results displayed that targeting GPC4 with CRISPR/Cas9 GPC4 attenuates the proliferation of glioblastoma cells and augments the proliferation of non-small cell lung adenocarcinoma cells in comparison with untreated cells and CRISPR controls (Figure 3B).